Exponent Q1 revenues $140.3M (+9.2% YoY), EPS $0.56; reiterates FY23 guidance

EXPONENT INC

2023-Q1 EPS reported $0.56 revenue$140,309,000

Revenues before reimbursements $128.7M, up 9.2% YoY; net income $29.1M, diluted EPS $0.56 (incl. $0.07 tax benefit).
Engineering segment revenues up 11% YoY (83% of revenues); environmental/health segment down 1% (up 2% ex-FX).
Q2 2023 guidance: revenue growth high-single to low-double digits; EBITDA margin 27.5%-28.5% of rev. Full year unchanged.
Declared quarterly cash dividend of $0.26/share, payable June 23, 2023, record June 9, 2023.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.97

EXPONENT INC reported first quarter ended March 31, 2023 results: revenue $140.3 million, net income $29.1 million, EPS $0.56 per diluted share. Guidance reaffirmed.

Period: first quarter ended March 31, 2023
Revenue: $140.3 million
Net income: $29.1 million
EPS: $0.56 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Total revenues and revenues before reimbursements for the first quarter of 2023 increased 9.2% to $140.3 million and $128.7 million, respectively, as compared to $128.5 million and $117.9 million in the first quarter of 2022, respectively. Net income was $29.1 million, or $0.56 per diluted share, in the first quarter of 2023, as compared to $29.6 million, or $0.56 per diluted share, in the same period of 2022.

View on SEC.gov

Browse all earnings releases →

EXPONENT INC filing history →

Source: SEC EDGAR

accession 0001171843-23-002639

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.